Correction to: Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022
- PMID: 37180596
- PMCID: PMC10171106
- DOI: 10.1093/ofid/ofad252
Correction to: Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022
Abstract
[This corrects the article DOI: 10.1093/ofid/ofac698.].
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Erratum for
-
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022.Open Forum Infect Dis. 2022 Dec 31;10(1):ofac698. doi: 10.1093/ofid/ofac698. eCollection 2023 Jan. Open Forum Infect Dis. 2022. PMID: 36695662 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
